NEUROCRINE BIOSCIENCES INC ($NBIX)
Filing Information
| Accession Number | 0001965808-26-000011 |
|---|---|
| Form Type | 4 |
| Filing Date | Jul 9, 2026 |
| Document | View SEC Filing |
Transactions
9
Total Shares
43,713
Total Value
$4,111,501.91
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Regulatory Officer | Common Stock | โ | Jul 7, 2026 | Exercise/Conversion | 3,401 | $103.52 | $352,071.52 | 19,626 | Direct | โ | View Details | |
Chief Regulatory Officer | Common Stock | โ | Jul 7, 2026 | Sale | 3,401 | $178.57 | $607,305.01 | 16,225 | Direct | โ | View Details | |
Chief Regulatory Officer | Common Stock | โ | Jul 8, 2026 | Exercise/Conversion | 2,737 | $103.52 | $283,334.24 | 18,962 | Direct | โ | View Details | |
Chief Regulatory Officer | Common Stock | โ | Jul 8, 2026 | Sale | 2,737 | $178.54 | $488,672.19 | 16,225 | Direct | โ | View Details | |
Chief Regulatory Officer | Common Stock | โ | Jul 9, 2026 | Exercise/Conversion | 8,433 | $103.52 | $872,984.16 | 24,658 | Direct | โ | View Details | |
Chief Regulatory Officer | Common Stock | โ | Jul 9, 2026 | Sale | 8,433 | $178.72 | $1,507,134.80 | 16,225 | Direct | โ | View Details | |
Chief Regulatory Officer | Non-Qualified Stock Option | Derivative | Jul 7, 2026 | Exercise/Conversion | 3,401 | $0.00 | $0.00 | 18,648 | Direct | โ | View Details | |
Chief Regulatory Officer | Non-Qualified Stock Option | Derivative | Jul 8, 2026 | Exercise/Conversion | 2,737 | $0.00 | $0.00 | 15,911 | Direct | โ | View Details | |
Chief Regulatory Officer | Non-Qualified Stock Option | Derivative | Jul 9, 2026 | Exercise/Conversion | 8,433 | $0.00 | $0.00 | 7,478 | Direct | โ | View Details |